Novartis agreed to pay $390 million in October 2015 to settle claims that it paid rebates to specialty pharmacies to push two of its drugs, without admitting wrongdoing.
swissinfo.ch
Swiss pharmaceutical giant Novartis must face a United States government lawsuit accusing it of paying millions of dollars in kickbacks to doctors so they would prescribe its drugs, Reuters reported.
A federal judge in Manhattan ruled on Monday that the US government had offered evidence of a “company-wide kickback scheme.” It also ruled that the government does not need to prove a direct “quid pro quo” deal between medics and doctors for the company to be liable.
The ruling means Novartis is headed for a trial – unless it settles.
“We are disappointed in today’s decision and look forward to presenting our case at trial,” Novartis spokesman Eric Althoff said in an email statement quoted by Reuters. “We continue to believe that the government has insufficient evidence to support its claims.”
The case took shape in 2011 when Oswald Bilotta, a former Novartis sales representative, filed a whistleblower lawsuit. The US government and the state of New York both intervened in the case in 2013.
Hypertension drugs and alleged sham events
Novartis is accused of paying doctors kickbacks so they would prescribe drugs such as the hypertension drugs Lotrel and Valturna, as well as Starlix, which is used in the treatment of diabetes.
The lawsuit claims that those kickbacks included speaking fees for doctors at “sham” educational events. One doctor was reportedly paid to speak at his own office eight times.
Novartis allegedly treated doctors to lavish meals, including a $9,750 (CHF 9,750) dinner for three at a Japanese restaurant.
American health insurance programs Medicare and Medicaid were billed millions of dollars from 2002 to 2011 for drugs prescribed by doctors who took kickbacks, according to the lawsuit said.
The US government is seeking damages of three times what it was billed for allegedly fraudulent claims. Novartis has settled US allegations that it used illegal methods to promote its medicines in the past.
In 2010, Novartis paid $422 million to settle various allegations, including claims of paying kickbacks to doctors.
Novartis agreed to pay $390 million in October 2015 to settle claims that it paid rebates to specialty pharmacies to push two of its drugs, without admitting wrongdoing.
More
More
US, Japan file complaints against Novartis
This content was published on
The New Jersey-based company boosted its sales of the iron-reduction drug Exjade by giving referrals and rebates to pharmacy BioScrip, which recommended refills to its patients but often failed to warn them of the drug’s potentially fatal side effects. These include kidney failure and gastrointestinal haemorrhaging, according to the complaint filed in Manhattan federal court…
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
Pope was a person full of respect: Swiss president
This content was published on
Swiss president Karin Keller-Sutter, who is attending the funeral of Pope Francis, says the pontiff was always full of respect.
Ex-sect member sentenced in Zurich for sexual abuse
This content was published on
Zurich District Court has sentenced a former member of the globally active sect "Children of God" to a partial prison sentence.
SNB chairman does not rule out slowdown in Swiss growth
This content was published on
Martin Schlegel, chairman of the Swiss National Bank (SNB), does not rule out a weakening of the Swiss economy in light of the tariff dispute.
Swiss NGOs abroad to receive 10% less federal funding
This content was published on
In 2025 and 2026, Swiss NGOs will have 10% less federal funding available for international cooperation than in the previous two-year period.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis hit by second US lawsuit in four days
This content was published on
On Friday, US Attorney Preet Bharara in Manhattan said the government had joined a whistle-blower lawsuit filed against Novartis Pharmaceuticals Corp in January 2011 which seeks triple damages under the federal False Claims Act. The government accused Novartis of causing the Medicare and Medicaid programmes to pay millions of dollars in reimbursements based on kickback-tainted…
This content was published on
The civil healthcare fraud lawsuit filed on Tuesday in a US district court in New York seeks unspecified damages and civil penalties for a scheme that the government said has been carried out since 2005. US Attorney Preet Bharara said in a statement the company used the “lure of kickbacks disguised as rebates” to turn…
Justice ministry confirms legal aid requests in Greece-Novartis scandal
This content was published on
The Federal Office of Justice has received two requests for legal assistance from Greece and the United States linked to probes into Novartis.
This content was published on
The employees are believed to have offered illegal rebates and kickbacks to doctors amounting to 2.6 billion won (CHF 2.3 million) between 2011 and 2016. Altogether, 34 people – including 15 doctors and five heads of medical journals – have been included in the investigation, which began in February when authorities raided the Novartis Korea…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.